Roshan Bastani

Roshan Bastani, Ph.D., is a professor in the Department of Health Policy and Management in the UCLA Fielding School of Public Health. She is Director of the UCLA Kaiser Permanente Center for Health Equity and Co-Director of the Center for Cancer Prevention and Control Research. In the Jonsson Comprehensive Cancer Center, she is Director for Disparities and Community Engagement and Co-Director of the Cancer Control and Survivorship program. She served an 11-year term as Associate Dean for Research in the School of Public Health.

Dr. Bastani is a social and health psychologist who has been conducting health equity intervention research for over 35 years, with a focus on implementing rigorous yet pragmatic individual, community, and especially system-directed intervention trials to improve quality of care and health outcomes. The goal of this work is to translate the benefits of evidence-based prevention, control and treatment strategies to the population at large. She has had continuous research funding from the National Institutes of Health since 1988.

Dr. Bastani has led a large number of studies, in both clinical and community settings, including among low-income, underinsured, ethnically minoritized and other underserved groups. Her research spans the developmental continuum and includes studies on cancer screening and diagnostic follow up; hepatitis B screening; tobacco control; melanoma prevention; obesity control; liver disease; and HPV vaccine uptake. Recent examples of her work include several system-focused pragmatic implementation trials to increase HPV vaccine uptake and colorectal cancer screening in the Los Angeles County Health Department and Federally Qualified Health Centers, and a system-level obesity prevention trial set in preschools.

Her research is conceptually grounded and includes strong and equitable community partnerships. She is the lead developer of the Multi-Level Health Outcomes Framework which is a socio-ecological conceptual model to guide descriptive and intervention research in disease prevention and control. Her methodological expertise includes qualitative and quantitative methods; research design; comparative effectiveness trials; program evaluation; implementation science; and utilization of electronic health records and other administrative databases for research.

Selected Publications

• Bastani R, Kaplan CP, Maxwell AE, Nisenbaum R, Pearce J, Marcus AC (1995). Initial and repeat mammography screening in a low income multi-ethnic population in Los Angeles. Cancer Epidemiology, Biomarkers & Prevention, 4(2):161-167. PMID: 7742724
• Bastani, R., Maxwell, A.E., Bradford, C., Prabhu Das, I., Yan, K. (1999). Tailored risk notification for women with a family history of breast cancer. Preventive Medicine, 29(5): 355-364. PMID: 10564627
• Bastani R, Berman BA, Belin TR, Crane LA, Marcus AC, Nasseri K, Herman-Shipley N, Bernstein S, Henneman CE (2002). Increasing cervical cancer screening among underserved women in a large urban county health system: Can it be done?  What does it take?  Medical Care. 40(10): 891-907. PMID: 12395023
• Bastani, R., Yabroff, K.R., Myers, R.E., Glenn, B. (2004). Interventions to improve follow-up of abnormal findings in cancer Screening. Cancer, 101(S5):1188-1200. PMCID: PMC1811062
• Mojica CM, Bastani R, Boscardin WJ, Ponce NA (2007). Low-income women with breast abnormalities: System predictors of timely diagnostic resolution. Cancer Control, 14(2):176-182. PMID: 17387303
• Bastani R, Glenn BA, Maxwell AE, Ganz PA, Mojica CM, Chang LC (2008). Validation of self-reported colorectal cancer (CRC) screening in a study of ethnically diverse first-degree relatives of CRC cases. Cancer Epidemiology, Biomarkers & Prevention, 17(4):791-798. PMID: 18381469
• Bastani R, Glenn BA, Taylor VM, Chen MS, Nguyen TT, Stewart SL, Maxwell AE (2010). Integrating theory into community interventions to reduce liver cancer disparities: The Health Behavior Framework. Preventive Medicine, 50(1-2):63-67. PMCID: PMC3243444
• Bastani R, Mojica CM, Berman BA, Ganz PA (2010). Low-income women with abnormal breast findings: Results of a randomized trial to increase rates of diagnostic resolution. Cancer Epidemiology, Biomarkers & Prevention, 19(8):1927-1936. PMID: 20647406
• Maxwell AE, Bastani R, Danao LL, Antonio C, Garcia GM, Crespi CM (2010). Results of a community-based randomized trial to increase colorectal cancer screening among Filipino Americans. American Journal of Public Health, 100(11):2228-2234. PMCID: PMC2951922
• Bastani R, Glenn BA, Tsui J, Chang LC, Marchand EJ, Taylor VM, Singhal R (2011). Understanding suboptimal human papillomavirus vaccine uptake among ethnic minority girls. Cancer Epidemiology, Biomarkers & Prevention, 20(7):1463-1472.  PMCID: PMC3132826
• Glenn BA, Bastani R, Maxwell AE, Mojica CM, Herrmann AK, Gallardo NV, Swanson KA, Chang LC (2012). Prostate cancer screening among ethnically diverse first-degree relatives of prostate cancer cases. Health Psychology, 31(5):562-570. PMID: 22708522
• Tsui J, Singhal R, Rodriguez HP, Gee GC, Glenn BA, Bastani R (2013). Proximity to safety-net clinics and HPV vaccine uptake among low-income, ethnic minority girls. Vaccine, 31(16):2028-2034. PMCID: PMC3629820
• Tu S, Chun A, Yasui Y, Kuniyuki A, Yip M, Taylor V, Bastani R (2014). Adaptation of an evidence-based intervention to promote colorectal cancer screening: A quasi-experimental study. Implementation Science, 9(85). PMCID: PMC4226971
• Bastani R, Glenn BA, Maxwell AE, Ganz PA, Mojica CM, Alber S, Chang LC (2015). Randomized Trial to Increase Colorectal Cancer Screening in an Ethnically Diverse Sample of First-Degree Relatives. Cancer, 121(17):2951-9. PMCID: PMC4545725
• Bastani R, Glenn BA, Jo AM, Herrmann AK, Crespi CM, Wong WK, Chang LC, Stewart SL, Nguyen TT, Chen MS, Taylor VM (2015). Cluster-Randomized Trial to Increase Hepatitis B Testing among Koreans in Los Angeles. Cancer Epidemiology, Biomarkers & Prevention, 24(9):1341-9. PMCID: PMC4560609
• Glenn BA, Lin T, Chang LC, Okada A, Wong WK, Glanz K, Bastani R (2015). Sun protection practices and sun exposure among children with a parental history of melanoma. Cancer Epidemiology, Biomarkers & Prevention, 24(1):169-77. PMCID: PMC4295624